Published in J Immunol on August 05, 2013
Promoter sequence of Shiga toxin 2 (Stx2) is recognized in vivo, leading to production of biologically active Stx2. MBio (2013) 0.84
Comparative genomics and immunoinformatics approach for the identification of vaccine candidates for enterohemorrhagic Escherichia coli O157:H7. Infect Immun (2014) 0.81
Protection of mice against Shiga toxin 2 (Stx2)-associated damage by maternal immunization with a Brucella lumazine synthase-Stx2 B subunit chimera. Infect Immun (2014) 0.80
Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites. Hum Vaccin Immunother (2014) 0.79
A Poly-N-acetylglucosamine-Shiga toxin broad-spectrum conjugate vaccine for Shiga toxin-producing Escherichia coli. MBio (2014) 0.78
Development of camelid single chain antibodies against Shiga toxin type 2 (Stx2) with therapeutic potential against Hemolytic Uremic Syndrome (HUS). Sci Rep (2016) 0.75
Characterization of structural and immunological properties of a fusion protein between flagellin from Salmonella and lumazine synthase from Brucella. Protein Sci (2017) 0.75
Retinoid levels influence enterohemorrhagic Escherichia coli infection and Shiga toxin 2 susceptibility in mice. Infect Immun (2014) 0.75
Immune Response in Calves Vaccinated with Type Three Secretion System Antigens and Shiga Toxin 2B Subunit of Escherichia coli O157:H7. PLoS One (2017) 0.75
Blue-light-activated histidine kinases: two-component sensors in bacteria. Science (2007) 2.65
Single domain antibodies: promising experimental and therapeutic tools in infection and immunity. Med Microbiol Immunol (2009) 1.94
Multiplex PCR assay for identification of human diarrheagenic Escherichia coli. J Clin Microbiol (2003) 1.66
Decrease of thrombomodulin contributes to the procoagulant state of endothelium in hemolytic uremic syndrome. Pediatr Nephrol (2003) 1.51
Complex energy landscape of a giant repeat protein. Structure (2013) 1.41
Hypothesis: an alternative pathway for the regulation of inflammation. Medicina (B Aires) (2004) 1.38
Bacillus subtilis DesR functions as a phosphorylation-activated switch to control membrane lipid fluidity. J Biol Chem (2004) 1.21
Galectin-3 and soluble fibrinogen act in concert to modulate neutrophil activation and survival: involvement of alternative MAPK pathways. Glycobiology (2004) 1.18
Shiga toxin-producing Escherichia coli in healthy young beef steers from Argentina: prevalence and virulence properties. Int J Food Microbiol (2004) 1.17
A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice. Infect Immun (2002) 1.11
Fibrinogen-CD11b/CD18 interaction activates the NF-kappa B pathway and delays apoptosis in human neutrophils. Eur J Immunol (2003) 1.07
Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used. Infect Immun (2003) 1.06
Structural mechanism for affinity maturation of an anti-lysozyme antibody. Proc Natl Acad Sci U S A (2004) 1.03
Single domain antibodies from llama effectively and specifically block T cell ecto-ADP-ribosyltransferase ART2.2 in vivo. FASEB J (2007) 1.00
High order quaternary arrangement confers increased structural stability to Brucella sp. lumazine synthase. J Biol Chem (2003) 0.99
Soluble fibrinogen modulates neutrophil functionality through the activation of an extracellular signal-regulated kinase-dependent pathway. J Immunol (2002) 0.99
Protective role of nitric oxide in mice with Shiga toxin-induced hemolytic uremic syndrome. Kidney Int (2002) 0.95
A polymeric bacterial protein activates dendritic cells via TLR4. J Immunol (2006) 0.94
Role of polymorphonuclear leukocytes in the pathophysiology of typical hemolytic uremic syndrome. ScientificWorldJournal (2007) 0.92
Discrete kinetic models from funneled energy landscape simulations. PLoS One (2012) 0.91
An atypical riboflavin pathway is essential for Brucella abortus virulence. PLoS One (2010) 0.91
Brucella outer membrane protein Omp31 is a haemin-binding protein. Microbes Infect (2006) 0.91
Crystallographic studies on decameric Brucella spp. Lumazine synthase: a novel quaternary arrangement evolved for a new function? J Mol Biol (2005) 0.91
Llama single domain antibodies as a tool for molecular mimicry. J Mol Biol (2005) 0.90
Development of DNA vaccines against hemolytic-uremic syndrome in a murine model. Infect Immun (2003) 0.90
The polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in rams. Vaccine (2009) 0.90
A DNA vaccine encoding the enterohemorragic Escherichia coli Shiga-like toxin 2 A2 and B subunits confers protective immunity to Shiga toxin challenge in the murine model. Clin Vaccine Immunol (2009) 0.89
Single-domain llama antibodies as specific intracellular inhibitors of SpvB, the actin ADP-ribosylating toxin of Salmonella typhimurium. FASEB J (2010) 0.89
Serotypes and Shiga toxin genotypes among Escherichia coli isolated from animals and food in Argentina and Brazil. Vet Microbiol (2003) 0.88
Brucella spp. lumazine synthase: a novel adjuvant and antigen delivery system to effectively induce oral immunity. Microbes Infect (2006) 0.88
Affinity maturation increases the stability and plasticity of the Fv domain of anti-protein antibodies. J Mol Biol (2007) 0.87
Light regulates attachment, exopolysaccharide production, and nodulation in Rhizobium leguminosarum through a LOV-histidine kinase photoreceptor. Proc Natl Acad Sci U S A (2012) 0.87
Antibody response to Shiga toxins in Argentinean children with enteropathic hemolytic uremic syndrome at acute and long-term follow-up periods. PLoS One (2011) 0.86
Relevance of the diversity among members of the Trypanosoma cruzi trans-sialidase family analyzed with camelids single-domain antibodies. PLoS One (2008) 0.86
The β-scaffold of the LOV domain of the Brucella light-activated histidine kinase is a key element for signal transduction. J Mol Biol (2012) 0.86
Functional capacity of Shiga-toxin promoter sequences in eukaryotic cells. PLoS One (2013) 0.86
Sequence determinants of quaternary structure in lumazine synthase. Mol Biol Evol (2003) 0.85
Interleukin-10 and interferon-gamma modulate surface expression of fractalkine-receptor (CX(3)CR1) via PI3K in monocytes. Immunology (2009) 0.85
Structure of the mature ectodomain of the human receptor-type protein-tyrosine phosphatase IA-2. J Biol Chem (2007) 0.85
Shiga toxin 1-induced inflammatory response in lipopolysaccharide-sensitized astrocytes is mediated by endogenous tumor necrosis factor alpha. Infect Immun (2009) 0.85
Improvement of the synthetic tri-peptide vaccine (S3Pvac) against porcine Taenia solium cysticercosis in search of a more effective, inexpensive and manageable vaccine. Vaccine (2006) 0.85
Promoter sequence of Shiga toxin 2 (Stx2) is recognized in vivo, leading to production of biologically active Stx2. MBio (2013) 0.84
Impaired neutrophils in children with the typical form of hemolytic uremic syndrome. Pediatr Nephrol (2005) 0.84
Brucella spp. lumazine synthase: a novel antigen delivery system. Vaccine (2005) 0.84
Structural and kinetic properties of lumazine synthase isoenzymes in the order Rhizobiales. J Mol Biol (2007) 0.83
Differential expression of function-related antigens on blood monocytes in children with hemolytic uremic syndrome. J Leukoc Biol (2005) 0.83
A DNA vaccine coding for the chimera BLSOmp31 induced a better degree of protection against B. ovis and a similar degree of protection against B. melitensis than Rev.1 vaccination. Vaccine (2007) 0.83
Tandem repeats of the extracellular domain of Matrix 2 influenza protein exposed in Brucella lumazine synthase decameric carrier molecule induce protection in mice. Vaccine (2012) 0.82
Immune response and serum bactericidal activity against Brucella ovis elicited using a short immunization schedule with the polymeric antigen BLSOmp31 in rams. Vet Immunol Immunopathol (2013) 0.82
Salmonella enterica serovar Typhimurium vaccine strains expressing a nontoxic Shiga-like toxin 2 derivative induce partial protective immunity to the toxin expressed by enterohemorrhagic Escherichia coli. Clin Vaccine Immunol (2010) 0.82
Exploring protein interfaces with a general photochemical reagent. Protein Sci (2006) 0.82
Involvement of the fractalkine pathway in the pathogenesis of childhood hemolytic uremic syndrome. Blood (2006) 0.82
Efficacy of a conjugate vaccine containing polymannuronic acid and flagellin against experimental Pseudomonas aeruginosa lung infection in mice. Infect Immun (2011) 0.82
Identification and characterization of RibN, a novel family of riboflavin transporters from Rhizobium leguminosarum and other proteobacteria. J Bacteriol (2013) 0.81
Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A. PLoS One (2012) 0.81
Advances in pathogenesis and therapy of hemolytic uremic syndrome caused by Shiga toxin-2. IUBMB Life (2013) 0.80
Polymeric Display of Proteins through High Affinity Leucine Zipper Peptide Adaptors. Biomacromolecules (2012) 0.80
Heterologous prime-boost oral immunization with GK-1 peptide from Taenia crassiceps cysticerci induces protective immunity. Clin Vaccine Immunol (2011) 0.80
Model of polymicrobial peritonitis that induces the proinflammatory and immunosuppressive phases of sepsis. Infect Immun (2010) 0.80
Brucella spp. lumazine synthase as a bovine rotavirus antigen delivery system. Vaccine (2008) 0.80
Protection of mice against Shiga toxin 2 (Stx2)-associated damage by maternal immunization with a Brucella lumazine synthase-Stx2 B subunit chimera. Infect Immun (2014) 0.80
A polymeric protein induces specific cytotoxicity in a TLR4 dependent manner in the absence of adjuvants. PLoS One (2012) 0.80
Chemokine receptor CCR1 disruption limits renal damage in a murine model of hemolytic uremic syndrome. Am J Pathol (2011) 0.79
Specific antibody-DNA interaction: a novel strategy for tight DNA recognition. Biochemistry (2003) 0.79
Renewed hope for a vaccine against the intestinal adult Taenia solium. J Parasitol (2007) 0.79
Escherichia coli ehl1 gene-positive serotype O18ac:H31 associated with an outbreak of diarrhea in a neonatal nursery in Neuquén City, Argentina. J Clin Microbiol (2002) 0.79
Specific recognition of a DNA immunogen by its elicited antibody. J Mol Biol (2007) 0.78
The functional state of neutrophils correlates with the severity of renal dysfunction in children with hemolytic uremic syndrome. Pediatr Res (2007) 0.78
The vaccine candidate BLSOmp31 protects mice against Brucella canis infection. Vaccine (2013) 0.78
Probing protein surface with a solvent mimetic carbene coupled to detection by mass spectrometry. J Am Soc Mass Spectrom (2011) 0.78
Antibody recognition of a flexible epitope at the DNA binding site of the human papillomavirus transcriptional regulator E2. Biochemistry (2006) 0.78
Shiga toxin-producing Escherichia coli O157 : H7 shows an increased pathogenicity in mice after the passage through the gastrointestinal tract of the same host. J Med Microbiol (2012) 0.78
Shiga toxin-producing Escherichia coli O157 in beef and chicken burgers, and chicken carcasses in Buenos Aires, Argentina. Int J Food Microbiol (2009) 0.77
The art of blocking ADP-ribosyltransferases (ARTs): nanobodies as experimental and therapeutic tools to block mammalian and toxin ARTs. FEBS J (2013) 0.77
Cytokine production is altered in monocytes from children with hemolytic uremic syndrome. J Clin Immunol (2012) 0.76